Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase. 1993

G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
Research Department 1, ICI Pharmaceuticals, Alderley Park, Macclesfield, UK.

Structure and activity relationships of (methoxyalkyl)thiazole and 4-methoxytetrahydropyran series of 5-lipoxygenase inhibitors are reviewed. One member of the 4-methoxytetrahydropyran series, 6-([fluoro-5-(4-methoxy-3,4,5,6-tetrahydro-2H-pyran-4-yl)phenoxy]methyl) -1- methylquinol-2-one (ICI D2138), is undergoing clinical evaluation.

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D011714 Pyrans Pyran
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D016859 Lipoxygenase Inhibitors Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. 5-Lipoxygenase Inhibitor,Lipoxygenase Inhibitor,12-Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors,Arachidonate 12-Lipoxygenase Inhibitors,Arachidonate 15-Lipoxygenase Inhibitors,Arachidonate 5-Lipoxygenase Inhibitors,Inhibitors, Lipoxygenase,12 Lipoxygenase Inhibitors,12-Lipoxygenase Inhibitors, Arachidonate,15 Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors, Arachidonate,5 Lipoxygenase Inhibitor,5 Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors, Arachidonate,Arachidonate 12 Lipoxygenase Inhibitors,Arachidonate 15 Lipoxygenase Inhibitors,Arachidonate 5 Lipoxygenase Inhibitors,Inhibitor, 5-Lipoxygenase,Inhibitor, Lipoxygenase,Inhibitors, 12-Lipoxygenase,Inhibitors, 15-Lipoxygenase,Inhibitors, 5-Lipoxygenase,Inhibitors, Arachidonate 12-Lipoxygenase,Inhibitors, Arachidonate 15-Lipoxygenase,Inhibitors, Arachidonate 5-Lipoxygenase
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
January 2002, Bioorganic & medicinal chemistry letters,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
December 1992, British journal of pharmacology,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
July 2010, ACS medicinal chemistry letters,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
September 1991, Agents and actions,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
March 1988, Journal of medicinal chemistry,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
April 1992, International journal of immunopharmacology,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
June 2007, Bioorganic & medicinal chemistry letters,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
April 2001, Bioorganic & medicinal chemistry,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
August 2011, Bioorganic & medicinal chemistry letters,
G C Crawley, and T G Bird, and P Bruneau, and R I Dowell, and P N Edwards, and S J Foster, and J M Girodeau, and R M McMillan, and E R Walker, and D Waterson
January 1993, Journal of lipid mediators,
Copied contents to your clipboard!